Li et al. reported that the mesenchymal cell marker, vimentin, was expressed in the progenitor cell of highly metastatic colon cancer but not in the progenitor cell of non-metastatic pancreatic cancer, indicating that EMT is correlated with the CSCs metastasis 35. Here, VIM is linked to colonic neoplasm.